Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - CASSAVA SCIENCES INC | sava-20191231xex32_1.htm |
| EX-31.2 - EX-31.2 - CASSAVA SCIENCES INC | sava-20191231xex31_2.htm |
| EX-31.1 - EX-31.1 - CASSAVA SCIENCES INC | sava-20191231xex31_1.htm |
| EX-4.2 - EX-4.2 - CASSAVA SCIENCES INC | sava-20191231xex4_2.htm |
| 10-K - 10-K - CASSAVA SCIENCES INC | sava-20191231x10k.htm |
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
1) |
Registration Statement (Form S-3 No. 333-217319) and related Prospectus of Cassava Sciences, Inc., |
|
2) |
Registration Statement (Form S-8 No. 333-168390) pertaining to the 2000 Employee Stock Purchase Plan of Pain Therapeutics, Inc., |
|
3) |
Registration Statement (Form S-8 No. 333-225708) pertaining to the 2018 Omnibus Incentive Plan of Pain Therapeutics, Inc., and |
|
4) |
Registration Statement (Form S-1 No. 333-228883) and related Prospectus of Cassava Sciences, Inc., |
of our report dated March 26, 2020, with respect to the financial statements of Cassava Sciences, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2019.
/s/Ernst &Young LLP
Austin, Texas
March 26, 2020